Financial Health Snapshot
What do Kenvue’s latest financial metrics say about health?
Kenvue is Mixed. The strongest factor is $221B in 2025 free cash flow, while the main concern is that $823B of total debt far exceeds $115B in cash.
The latest verified period is Q1 2026 for operating results, with cash and debt measured on June 09, 2026. This verdict combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency, so it reflects both current momentum and financial flexibility. For background on the business model, see Kenvue Inc.: History, Ownership, Mission, How It Works & Makes Money.
Free cash flow deserves deeper analysis first because it shows whether Kenvue can keep funding operations, reduce leverage, and support future spending.
Revenue and Earnings Quality
Are Kenvue’s revenue and earnings durable enough?
Mixed. Kenvue’s sales are still supported by recurring consumer health demand, but the clearest divergence is that Q1 2026 revenue strength is easier to verify than full earnings conversion, and the 2025 Diluted EPS of $086 trails the Adjusted Diluted EPS of $121.
Kenvue’s revenue quality looks better than its reported earnings quality. Investors compare durable sales with operating income, net income, and diluted EPS across compatible periods because growth only matters if it turns into repeatable profit, not just a bigger top line. For mission context, see Mission Statement, Vision, & Core Values (2026) of Kenvue Inc.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $395B in Q1 2026, up 12% year over year | Q1 2025 revenue not supplied in the prompt | Likely recurring consumer demand; exact price-volume split is unavailable | The growth looks repeatable if category demand stays steady |
| Operating Income | Not supplied | Not supplied | Cannot verify operating leverage from the prompt | No clear proof yet that sales growth is flowing through to operating profit |
| Net Income | $164B in 2025 | Prior comparable net income not supplied | Underlying result is harder to judge without same-period comparison | Reported profit exists, but durability is less clear than revenue visibility |
| Diluted EPS | $086 in 2025 | Prior comparable diluted EPS not supplied | Adjusted Diluted EPS of $121 shows reported earnings were lower than adjusted earnings | Shareholders saw weaker reported per-share earnings than adjusted results suggested |
How durable is Kenvue’s revenue?
The strongest durability signal is recurring demand across Self Care, Skin Health and Beauty, and Essential Health. The biggest limitation is customer concentration, since the top five retail customers represent approximately 35% of total global sales.
- Demand Quality: Demand is defensive and recurring, but retailers can still manage inventory tightly.
- Pricing and Volume: The prompt gives overall sales growth, but the price-versus-volume split is unavailable.
- Diversification: Q1 2026 mix was Self Care 42.1%, Skin Health and Beauty 24.8%, and Essential Health 33.1%; retail concentration remains notable.
That combination points investors toward margin control and cash conversion next.
Cash Quality
How much of Kenvue’s profit turns into cash?
Kenvue’s margins and cash flow point to solid cash generation, even with heavier spending and outside pressures. Q1 2026 adjusted EBITDA margin was 234%, while 2025 net income was $164B, operating cash flow was $284B, and free cash flow was $221B.
Kenvue’s gross margin shows product economics, operating margin shows how well the business covers overhead, and net margin shows what is left after all costs. Cash flow adds the other half of the picture: operating cash flow shows cash from day-to-day business, capital expenditure reduces it, and free cash flow is what remains for reinvestment, debt, or returns. For mission and strategy context, see Mission Statement, Vision, & Core Values (2026) of Kenvue Inc.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Q1 2026 adjusted EBITDA margin: 234% | Not provided | May 2024 productivity program targeting $350M in annual pre-tax cost savings by 2026 | Suggests stronger unit economics if savings hold and feed through to profitability |
| Operating Margin | Q1 2026 adjusted EBITDA margin: 234% | Not provided | Cost savings from productivity actions, but offset by higher marketing and freight costs | Shows whether scale and discipline are improving operating efficiency |
| Net Margin | 2025 net income: $164B | Not provided | Foreign currency fluctuations negatively impacted reported net sales by $210M | Shows final profit after all costs, but currency can distort the reported result |
| Operating Cash Flow | 2025 operating cash flow: $284B | FMP 2026-03-29 Operating Cash Flow Growth: -4274% | Cash generation remained positive despite working-capital and expense pressure | Suggests reported earnings are being converted into operating cash |
| Free Cash Flow | 2025 free cash flow: $221B | FMP 2026-03-29 Free Cash Flow Growth: -5296% | Free cash flow is operating cash flow after capital spending | Shows cash left for reinvestment, financing, and shareholder support |
What most affects Kenvue’s cash conversion?
The biggest driver is the gap between cash generation and spending, especially higher marketing and freight costs versus the productivity program’s savings. That points to a mixed but still manageable cash-conversion profile.
- Main Driver: $112B marketing and advertising spend, plus higher freight costs, looks temporary unless sustained by strategy.
- Evidence Gap: The supplied data does not separate working-capital changes from other cash-flow drivers.
- Metric to Monitor: Operating margin and free cash flow after capital expenditure.
Liquidity Check
Can Kenvue support its debt without liquidity stress?
Mixed. Kenvue’s balance sheet is workable, but not low-risk: $823B of debt is far above $115B of cash. The main protection is strong internal cash generation, while the main financing concern is working-capital pressure if retailer destocking tightens cash conversion.
Cash alone does not tell the full story, so the key test is working capital, asset quality, debt service, solvency, liquidity, and refinancing together. Kenvue’s 2025 operating cash flow of $284B and free cash flow of $221B show internal funding capacity, while March 2026 Federal Reserve rate stability may help make floating-rate debt costs more predictable, not safer. For company background, see Mission Statement, Vision, & Core Values (2026) of Kenvue Inc.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash and Cash Equivalents: $115B; top five retail customers represent approximately 35% of total global sales; inventory turnover time improved by 4 days compared to March 2025. | Mixed | Liquidity is supported by cash and better inventory use, but customer concentration and destocking can still strain near-term cash needs. |
| Total and Net Debt | Total Debt: $823B; cash is lower than debt, so net debt remains positive. | Weak | Leverage is a real constraint, so debt reduces flexibility even though it does not automatically create a crisis. |
| Debt Service and Refinancing | 2025 Operating Cash Flow: $284B; Free Cash Flow: $221B; March 2026 US Federal Reserve rate stability may help keep floating-rate servicing more predictable. | Mixed | Kenvue appears able to cover debt service from operations, but refinancing still depends on access to capital and stable cash generation. |
| Asset Quality | Inventory turnover time improved by 4 days versus March 2025; major retailer destocking remains a watchpoint. | Mixed | Working capital is improving, but slower customer orders could still tie up cash and pressure asset efficiency. |
| Liabilities and Equity | Total liabilities and shareholders' equity were not supplied in the prompt. | Mixed | Book leverage cannot be fully assessed here, so investors should focus on cash flow strength and debt trends. |
Which balance-sheet risk matters most for Kenvue?
Working-capital pressure matters most. Debt is large, but the sharper near-term risk is retailer destocking and customer concentration, which could slow cash conversion before refinancing becomes the bigger issue.
- Current Exposure: Top five retail customers represent approximately 35% of total global sales, so customer behavior can move cash quickly.
- Protection: 2025 Operating Cash Flow of $284B and Free Cash Flow of $221B give Kenvue internal funding power.
- Warning Signal: Watch for renewed retailer destocking or a reversal in the 4 days inventory-turnover improvement.
Capital Efficiency
Can Kenvue fund growth and shareholder returns internally?
Kenvue’s capital efficiency looks Mixed, but internal cash appears likely enough to support reinvestment needs. The key caveat is that dividend and buyback coverage cannot be confirmed from the supplied cash outflow data alone.
Return analysis should be read alongside leverage, asset intensity, capex, working capital, and any outside funding needs. Kenvue’s reinvestment profile also ties to its Kenvue Inc.: History, Ownership, Mission, How It Works & Makes Money profile, especially the focus on brands, cash generation, and disciplined capital allocation.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable in the supplied data. | ROIC would be more convincing if operating margins and asset use stay efficient while the business keeps funding brand investment. | Without the ratio, it is not possible to judge whether invested capital is clearly creating operating value. |
| ROE and ROA | Unavailable in the supplied data. | ROE could be lifted by leverage, while ROA depends on how much asset intensity the business carries. | Shareholder return quality and asset efficiency cannot be confirmed from the supplied figures alone. |
| Maintenance and Growth Investment | 2025 R&D Investment: $415M; Our Future Ready targets increased investment in 15 priority brands to drive 60% of long-term growth; May 2024 share repurchase authorization of up to 25M shares. | R&D supports product claims, clinical credentials, and innovation across Neutrogena, Aveeno, Band-Aid, and Listerine; the productivity program helps fund this. | Capital needs appear focused on sustaining brand strength and growth, not just maintaining current operations. |
| Internal Funding Capacity | 2025 Free Cash Flow: $221B; Q1 2026 Dividend Declared: $0.20 per share. | Internal cash generation appears supportive, but the exact dividend and buyback cash outflows were not supplied. | Investment appears at least partly internally funded, with ongoing monitoring needed for leverage, dilution, and flexibility. |
Are Kenvue’s returns on capital sustainable?
The strongest durability source is brand-led margin support from the productivity program and focused R&D. Returns could weaken if marketing, R&D, capex, dividends, and buybacks outgrow cash generation or force higher leverage.
- Operating Source: Brand mix, R&D-backed product claims, and the productivity program support margins and cash flow.
- Funding Requirement: The largest verified capital needs are 2025 R&D Investment: $415M and ongoing shareholder return commitments.
- Durability Test: Returns weaken if free cash flow, leverage, or working capital pressure no longer covers reinvestment and capital returns.
Financial Resilience
How resilient is Kenvue, and which warning signs matter most?
Kenvue is Mixed. The main buffer is its $221B 2025 free cash flow, plus broad geographic sales and cost savings from its productivity program. The most important warning sign is retail concentration, since the top five retail customers represent about 35% of total global sales.
Kenvue’s resilience depends on whether it can keep turning consumer demand into cash while absorbing retailer inventory swings, freight shocks, and legal costs. The business spans more than 165 countries and three operating segments, and its productivity program targets $350M in annual pre-tax cost savings by 2026, which helps protect liquidity. For background on the company’s structure and model, see Kenvue Inc.: History, Ownership, Mission, How It Works & Makes Money.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Top-five retail customers represent about 35% of total global sales, so destocking can delay revenue, weaken operating leverage, and reduce cash flow and debt capacity. | Broad geographic sales across more than 165 countries and three operating segments soften dependence on any one market. | Falling net sales, margin compression, or lower cash generation tied to retailer inventory reduction. |
| Working-Capital or Investment Pressure | Inventory destocking and slower sell-through can tie up cash and make working capital less predictable, especially if sales timing shifts. | Recurring consumer demand and the productivity program targeting $350M in annual pre-tax cost savings by 2026 support internal funding. | Weak operating cash flow, rising inventory, or higher cash use for working capital and investment. |
| Interest or Refinancing Pressure | Freight cost inflation and legal costs can reduce free cash flow and leave less flexibility for debt service and refinancing. | Current free cash flow and the company’s scale provide some cushion against near-term funding stress. | Rising interest expense, tighter liquidity, or weaker free cash flow relative to obligations. |
Which financial warning signs should investors monitor at Kenvue?
Watch retail concentration and inventory destocking first, then freight and currency pressure, then legal overhangs. The first two already affect sales timing and costs; the legal cases are a continuing risk that could weigh on cash and sentiment.
Retail concentration and destocking
Top five retail customers account for about 35% of global sales, so inventory cuts can hit revenue timing and working capital. The next metric is sell-through and net sales at major retailers.
Currency and freight cost pressure
Foreign currency fluctuations reduced reported net sales by $210M, and Red Sea shipping disruptions raised freight costs for EMEA shipments by 85%. The next metric is reported sales versus constant-currency sales and freight trends.
Legal overhang from talc and benzene claims
Continued talc-related claims and ongoing benzene-related class-action litigation can create cash, legal, and sentiment risk. Johnson & Johnson provides general indemnification for pre-separation North America talc liabilities, so the next metric is litigation status and related charges.
Balanced Health Scorecard
What does Kenvue Inc. financial health mean for investors?
Kenvue Inc. scores Mixed overall. Its strongest factor is cash generation, while the weakest is the debt load relative to cash. The investment case hinges most on whether steady consumer health demand can keep funding debt service, reinvestment, and returns. For background, see Kenvue Inc.: History, Ownership, Mission, How It Works & Makes Money.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Mixed | 2025 Total Net Sales were $15.72B, and Q1 2026 net sales rose 12%, but growth is modest and retail concentration matters. |
| Profitability and Cash | Strong | Q1 2026 adjusted EBITDA margin was 23.4%, and 2025 Free Cash Flow was $2.21B, showing solid cash conversion and funding capacity. |
| Balance Sheet and Liquidity | Mixed | Cash was $1.15B versus total debt of $8.23B, while 2025 Operating Cash Flow was $2.84B, so liquidity is workable but leverage stays high. |
| Capital Efficiency | Mixed | Free cash flow can support reinvestment and capital returns, but no verified ROIC, ROE, or ROA is supplied to judge efficiency. |
| Financial Resilience | Mixed | Consumer health demand is steady, but currency, freight, retailer concentration, and legal overhangs remain pressure points to watch. |
- What Supports the Thesis: Resilient brand portfolio and internal funding from strong cash generation.
- What Challenges the Thesis: Leverage is heavy relative to cash, with cost and legal risks still unresolved.
- What to Monitor: Q2 2026 net sales growth, free cash flow, and total debt versus cash.
That mix makes forecast quality important, because scenario analysis and valuation will depend on how reliably Kenvue Inc. converts sales into cash while managing debt and costs.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
Why can free cash flow exceed net income?
Free cash flow starts with operating cash flow and then subtracts capital spending Kenvue reported 2025 Net Income of $164B, Operating Cash Flow of $284B, and Free Cash Flow of $221B, showing that cash generation was stronger than accounting profit that year
How much debt does Kenvue hold versus cash?
As of June 09, 2026, Kenvue had Cash and Cash Equivalents of $115B and Total Debt of $823B That gap makes operating cash flow important because cash on hand alone does not offset the debt load
Does customer concentration affect Kenvue liquidity?
Yes, it can affect timing of sales, receivables, and inventory Kenvue’s top five retail customers represent approximately 35% of total global sales, so retailer ordering patterns and destocking can influence working-capital needs even when consumer demand remains resilient
Are dividends and buybacks internally funded?
Kenvue generated 2025 Free Cash Flow of $221B and declared a Q1 2026 dividend of $020 per share The board also authorized repurchases of up to 25M shares to offset dilution, but exact total cash uses must be checked against future cash-flow statements
Which cost pressures matter most for margins?
Currency, freight, marketing, and regulatory costs are the main verified pressures Foreign currency fluctuations negatively impacted reported net sales by $210M, Red Sea disruptions increased EMEA freight costs by 85%, and marketing spend rose to $112B in 2025